E-ISSN 2536-9520 | ISSN 1110-2047
 

Review Article 


A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes

Ashraf A. Shamaa, Ahmed N. Abdallah, Mohamed M. Bahr, Omar S. El-tookhy.


Abstract
Multiple sclerosis (MS) is a chronic autoimmune disease which influences the neurons of the central nervous system by chronic demyelination. The immune system attacks the myelin sheath and the oligodendrocyte leading to oligodendroglial cells loss, glial scarring and the remyelination stops setting off irreversible damage. The MS is classified into 4 categories: Relapsing–remitting which is considered the most common (about 85% of cases), Secondary progressive, Primary progressive and Progressive-relapsing. The treatment of MS with disease-modifying agents aims to shorten the duration of acute relapses and decreasing relapses frequency. Until now, no curative FDA-approved therapies exist, but there are 8 FDA-approved therapeutic agents able to reduce the disease progression in the relapsing forms of MS. The available therapies are immunosuppressive or immunomodulatory drugs which preclude or delay MS progression. Regenerative medicine via MSCs could play an important role in regeneration a damaged neural tissue as MSCs not only have ability for neurogeneration but also have immunoregulative function which can control and treat MS. Exosomes derived from MSCs offer a good alternative surpassing the possible drawbacks of using MSCs such as tumorigenicity and immune rejection.

Key words: MS-treatments, regenerative-drugs, MSCs, exosomes.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ashraf A. Shamaa
Articles by Ahmed N. Abdallah
Articles by Mohamed M. Bahr
Articles by Omar S. El-Tookhy
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Shamaa AA, Abdallah AN, Bahr MM, El-tookhy OS. A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes. AJVS. 2020; 66(2): 30-39. doi:10.5455/ajvs.125962


Web Style

Shamaa AA, Abdallah AN, Bahr MM, El-tookhy OS. A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes. https://www.alexjvs.com/?mno=125962 [Access: May 04, 2025]. doi:10.5455/ajvs.125962


AMA (American Medical Association) Style

Shamaa AA, Abdallah AN, Bahr MM, El-tookhy OS. A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes. AJVS. 2020; 66(2): 30-39. doi:10.5455/ajvs.125962



Vancouver/ICMJE Style

Shamaa AA, Abdallah AN, Bahr MM, El-tookhy OS. A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes. AJVS. (2020), [cited May 04, 2025]; 66(2): 30-39. doi:10.5455/ajvs.125962



Harvard Style

Shamaa, A. A., Abdallah, . A. N., Bahr, . M. M. & El-tookhy, . O. S. (2020) A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes. AJVS, 66 (2), 30-39. doi:10.5455/ajvs.125962



Turabian Style

Shamaa, Ashraf A., Ahmed N. Abdallah, Mohamed M. Bahr, and Omar S. El-tookhy. 2020. A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes. Alexandria Journal of Veterinary Sciences, 66 (2), 30-39. doi:10.5455/ajvs.125962



Chicago Style

Shamaa, Ashraf A., Ahmed N. Abdallah, Mohamed M. Bahr, and Omar S. El-tookhy. "A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes." Alexandria Journal of Veterinary Sciences 66 (2020), 30-39. doi:10.5455/ajvs.125962



MLA (The Modern Language Association) Style

Shamaa, Ashraf A., Ahmed N. Abdallah, Mohamed M. Bahr, and Omar S. El-tookhy. "A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes." Alexandria Journal of Veterinary Sciences 66.2 (2020), 30-39. Print. doi:10.5455/ajvs.125962



APA (American Psychological Association) Style

Shamaa, A. A., Abdallah, . A. N., Bahr, . M. M. & El-tookhy, . O. S. (2020) A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes. Alexandria Journal of Veterinary Sciences, 66 (2), 30-39. doi:10.5455/ajvs.125962





Most Viewed Articles
Most Downloaded
Most Cited Articles